Experimental studies in genetically modified mice and diet-induced NAFLD suggest that alterations in GNMT, MAT1A, and ACHY expression can contribute to NASH development in humans [72, 80, 87]. Here, MAT1A is linked to metabolic dysfunction-associated steatohepatitis.